QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.106583v1 319/2/561    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Madras, B. K. Articles by Fischman, A. J. Search for Related Content PubMed PubMed Citation Articles by Madras, B. K. Articles by Fischman, A. J.

NEUROPHARMACOLOGY

Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro

Department of Psychiatry, Harvard Medical School and New England Primate Research Center, Southborough, Massachusetts (B.K.M., Z.X., Z.L., A.J., H.P., L.L., R.J., G.M.M.); and Massachusetts General Hospital, Boston, Massachusetts (E.L., T.J.S., A.A.B., A.J.F.)

2-[(Diphenylmethyl) sulfinyl]acetamide (modafinil), prescribed principally to treat narcolepsy, is undergoing assessment for other neuropsychiatric disorders and medical conditions. The neurochemical substrates of modafinil are unresolved. We postulated that modafinil enhances wakefulness by modulating dopamine (DAT), norepinephrine (NET), or serotonin (SERT) transporter activities. In vivo, we determined DAT and NET occupancy by modafinil by positron emission tomography imaging; in vitro, we determined modafinil activity at the DAT, NET, SERT, and rhesus monkey trace amine receptor 1 (TA1). In rhesus monkey, modafinil occupancy of striatal DAT was detected by [¹¹C]2-carbomethoxy-3-4-(fluorophenyl)tropane and of thalamic NET by [¹¹C](S,S)-2-(-(2-methoxyphenoxy)-benzyl)morpholine. In vitro, modafinil effects in DAT-human embryonic kidney (HEK), NET-HEK, and SERT-HEK cells were investigated alone or combined with the TA1 receptor. Modafinil (i.v.) occupied striatal DAT sites (5 mg/kg: 35 ± 12%, n = 4; 8 mg/kg: 54 ± 3%, n = 3). In thalamus, modafinil occupied NET sites (5 mg/kg: 16 ± 7.8%, n = 6; 8 mg/kg: 44 ± 12%; n = 2). In vitro, modafinil inhibited [³H]dopamine (IC₅₀ = 6.4 µM), [³H]norepinephrine (IC₅₀ = 35.6 µM), and [³H]serotonin (IC₅₀ > 500 µM) transport via the human DAT, NET, and SERT. Modafinil did not activate the TA1 receptor in TA1-HEK cells, but it augmented a monoamine transporter-dependent enhancement of phenethylamine activation of TA1 in TA1-DAT and TA1-NET cells, but not in TA1-SERT cells. The present data provide compelling evidence that modafinil occupies the DAT and NET in living brain of rhesus monkeys and raise the possibility that modafinil affects wakefulness by interacting with catecholamine transporters in brain.

Address correspondence to: Dr. Bertha K. Madras, Department of Psychiatry, Harvard Medical School, New England Primate Research Center, 1 Pine Hill Dr., Southborough, MA 01772-9102. E-mail: bertha_madras{at}hms.harvard.edu

This article has been cited by other articles:

				D. Zolkowska, R. Jain, R. B. Rothman, J. S. Partilla, B. L. Roth, V. Setola, T. E. Prisinzano, and M. H. Baumann Evidence for the Involvement of Dopamine Transporters in Behavioral Stimulant Effects of Modafinil J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 738 - 746. [Abstract] [Full Text] [PDF]

				N. D. Volkow, J. S. Fowler, J. Logan, D. Alexoff, W. Zhu, F. Telang, G.-J. Wang, M. Jayne, J. M. Hooker, C. Wong, et al. Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain: Clinical Implications JAMA, March 18, 2009; 301(11): 1148 - 1154. [Abstract] [Full Text] [PDF]

				J. W. Young Dopamine D1 and D2 Receptor Family Contributions to Modafinil-Induced Wakefulness J. Neurosci., March 4, 2009; 29(9): 2663 - 2665. [Full Text] [PDF]

				M. J. Minzenberg, A. J. Watrous, J. H. Yoon, S. Ursu, and C. S. Carter Modafinil Shifts Human Locus Coeruleus to Low-Tonic, High-Phasic Activity During Functional MRI Science, December 12, 2008; 322(5908): 1700 - 1702. [Abstract] [Full Text] [PDF]

				Z. Xie and G. M. Miller {beta}-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 617 - 628. [Abstract] [Full Text] [PDF]

				Z. Xie, S. V. Westmoreland, and G. M. Miller Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 629 - 640. [Abstract] [Full Text] [PDF]

				C. D Verrico, L. Lynch, M. A Fahey, A.-K. Fryer, G. M Miller, and B. K Madras MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor J Psychopharmacol, March 1, 2008; 22(2): 187 - 202. [Abstract] [PDF]

				G. Bush, T. J. Spencer, J. Holmes, L. M. Shin, E. M. Valera, L. J. Seidman, N. Makris, C. Surman, M. Aleardi, E. Mick, et al. Functional Magnetic Resonance Imaging of Methylphenidate and Placebo in Attention-Deficit/Hyperactivity Disorder During the Multi-Source Interference Task Arch Gen Psychiatry, January 1, 2008; 65(1): 102 - 114. [Abstract] [Full Text] [PDF]

				S. Morein-Zamir, D. C. Turner, and B. J. Sahakian A Review of the Effects of Modafinil on Cognition in Schizophrenia Schizophr Bull, November 1, 2007; 33(6): 1298 - 1306. [Abstract] [Full Text] [PDF]